🔎 Trials Near Me

Home › Soft Tissue Sarcoma › Tennessee

Soft Tissue Sarcoma clinical trials in Tennessee

18 studies for Soft Tissue Sarcoma are looking for participants at sites in Tennessee.

Cities in Tennessee

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1/2
Ages 2 to 30 · All sexes · Updated Nov 5, 2026 · NCT05734066

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1/2
Up to age 25 · All sexes · Updated Sep 25, 2026 · NCT04094610

DESTINY-PANTUMOUR04

  • Research Site, Nashville
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  • Sarah Cannon Tennessee Oncology, Nashville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05732831

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • Vanderbilt University School of Medicine, Nashville
RecruitingPhase 1
Ages 12 to 85 · All sexes · Updated Sep 8, 2026 · NCT03715933

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

  • Sarah Cannon Research Institute, Nashville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06644755

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

  • St. Jude Children's Research Hospital, Memphis
Recruiting
All ages · All sexes · Updated Aug 21, 2026 · NCT07514819

Enhanced Recovery After Surgery in Extremity Sarcoma

  • Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT04461171

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

  • St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272

Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients

  • St. Jude Children's Research Hospital, Memphis
RecruitingObservational studyHealthy volunteers welcome
Ages 5 to 20 · All sexes · Updated Jun 18, 2026 · NCT07502885

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Baptist Memorial Hospital Baptist Cancer Center, Memphis
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

  • St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Up to age 21 · All sexes · Updated May 19, 2026 · NCT04897321

Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas

  • St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Up to age 21 · All sexes · Updated Feb 9, 2026 · NCT07222735

Molecular Analysis Of Solid Tumors

  • St. Jude Children's Research Hospital, Memphis
RecruitingObservational study
Up to age 25 · All sexes · Updated Nov 12, 2025 · NCT01050296

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

  • Vanderbilt University/Ingram Cancer Center, Nashville
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Sep 19, 2025 · NCT06482957

Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas

  • Vanderbilt-Ingram Cancer Center, Nashville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 28, 2025 · NCT04506008

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.